logo

For the Inventor, By the Inventor

Belleville, NJ, United States of America

Center for Molecular Medicine and Immunology


USPTO Granted Patents = 19



Forward Citations = 924

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal David M Goldenberg (13 out of 393 patents)

silverMedal Rosalyn D Blumenthal (5 out of 5 patents)

bronzeMedal David E Modrak (3 out of 3 patents)

4.  Thomas M Behr (3 out of 3 patents)

5.  Alice P Taylor (2 out of 2 patents)

6.  Milton D Goldenberg (2 out of 26 patents)

7.  Lisa B Shih (2 out of 2 patents)

8.  Frederick J Primus (2 out of 3 patents)

9.  Chien-Hsing Chang (1 out of 140 patents)

10.  Chien Hsing Chang (1 out of 8 patents)

11.  Michael K Samoszuk (1 out of 5 patents)

12.  Jack D Burton (1 out of 1 patent)

13.  Walter Lew (1 out of 1 patent)

14.  Malik Juweid (1 out of 1 patent)

15.  Rita Alisauskas (1 out of 1 patent)


19 patents:

1. 7932212 - Inhibition of placenta growth factor (PlGF) mediated metastasis and/or angiogenesis (2011-04-26),
2. 7683044 - Sphingomyelin therapy of autoimmune disease (2010-03-23),
3. 7642239 - Inhibition of placenta growth factor (PLGF) mediated metastasis and/or angiogenesis (2010-01-05),
4. 7465551 - Method of determining cytokine dosage for improving myelosuppressive state (2008-12-16),
5. 7288534 - Sphingomyelin enhancement of tumor therapy (2007-10-30),
6. 7279289 - Method of evaluating myelosuppressive state (2007-10-09),
7. 7220399 - Alpha or beta emitters attached to fragments in radioimmunotherapy (2007-05-22),
8. 7112409 - Method of determining cytokine dosage for myelosuppressive state (2006-09-26),
9. 6703488 - Antibody/receptor targeting moiety for enhanced delivery of armed ligand (2004-03-09),
10. 6667024 - Alpha or beta emitters attached to fragments in radioimmunotherapy (2003-12-23),
11. 6649352 - Method of evaluating myelosuppressive state (2003-11-18),
12. 6541462 - Sphingomyelin enhancement of tumor therapy (2003-04-01),
13. 6540980 - Method of detecting endometriosis (2003-04-01),
14. 5843894 - Methods for reduced renal uptake of antibody fragments (1998-12-01),
15. 5759514 - Composition for delivery of toxic radioisotopes to the cell nucleus and (1998-06-02),
The Center for Molecular Medicine and Immunology (CMMI) is a non-profit research organization dedicated to advancing the understanding and treatment of human diseases through molecular and immunological research. With state-of-the-art facilities and a team of renowned scientists, CMMI conducts cutting-edge research to develop innovative therapies for a wide range of conditions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#2 in Belleville, NJ

#646 in New Jersey

#16,627 in US

#31,709 in the World

...
Belleville, NJ, United States of America

Center for Molecular Medicine and Immunology

Forward Citations = 924

19 inventors:

goldMedal David M Goldenberg (13 out of 393 patents)

silverMedal Rosalyn D Blumenthal (5 out of 5 patents)

bronzeMedal David E Modrak (3 out of 3 patents)

4.  Thomas M Behr (3 out of 3 patents)

5.  Alice P Taylor (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com
Loading…